rosiglitazone has been researched along with Atrophy, Muscle in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS | 1 |
Chen, SZ; Xiao, JD | 1 |
Chevalier, S; Farsijani, S | 1 |
Asp, ML; Belury, MA; Tian, M; Wendel, AA | 1 |
Du, J; Hu, J; Hu, Z; Mitch, WE; Wang, X | 1 |
1 review(s) available for rosiglitazone and Atrophy, Muscle
Article | Year |
---|---|
Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
Topics: Adipose Tissue; Animals; Cachexia; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Muscular Atrophy; Neoplasms; Nutritional Support; Proteins; Rosiglitazone; Thiazolidinediones | 2014 |
4 other study(ies) available for rosiglitazone and Atrophy, Muscle
Article | Year |
---|---|
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Cachexia; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Imidazolidines; Inflammation Mediators; Insulin; Male; Mice; Muscle Proteins; Muscles; Muscular Atrophy; Neoplasms; Organ Size; Rosiglitazone; SKP Cullin F-Box Protein Ligases; Thiazolidinediones; Tripartite Motif Proteins; Tumor Burden; Ubiquitin-Protein Ligases | 2014 |
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Topics: Adenocarcinoma; Adiponectin; Animals; Autophagy; Blood Glucose; Cachexia; Colonic Neoplasms; Crosses, Genetic; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Neoplasm Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Random Allocation; Rosiglitazone; Thiazolidinediones; Weight Loss | 2010 |
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Topics: 3T3-L1 Cells; Adiponectin; Animals; Blood Glucose; Caspase 3; Caspases; Gene Expression; Hypoglycemic Agents; Insulin; Insulin Resistance; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Cells; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Phosphatidylinositol 3-Kinases; Phosphorylation; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha; Ubiquitin | 2006 |